Skip to main content
FEMY
NASDAQ Industrial Applications And Services

Femasys Q2 2026: Sales Fall 18.9%, Net Loss Narrows to $4.47M; $30M Private Placement Closed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.34
Mkt Cap
$6.915M
52W Low
$2.19
52W High
$22.2
52W Position info
6.8% above low
Off High info
89% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

FEMY is trading near its 52-week low of $2.19 (6.8% above the low).

Summary

Femasys Q2 2026 sales fell 18.9% to $331,827, net loss narrowed to $4.47M, and a $30M private placement closed August 10, 2026, providing liquidity.


Key Events · Earnings and Guidance · FEMY

  • Q2 Sales Decline

    Sales fell 18.9% year-over-year to $331,827, driven by lower international FemVue sales.

  • Net Loss Narrows

    Net loss was $4.47M, improved from $4.59M a year ago, helped by non-cash gains on derivative liabilities.

  • $30M Private Placement

    Closed August 10, 2026: 9,374,999 shares at $3.20 plus warrants for 18,749,998 shares at $2.95 exercise price.

  • Cash Position

    Cash was $1.4M at June 30, 2026; the private placement provides additional liquidity.


Analysis · FEMY · Industrial Applications And Services

Femasys reported Q2 2026 sales of $331,827, down 18.9% year-over-year, while net loss narrowed to $4.47M from $4.59M. The company also disclosed a $30M private placement completed August 10, 2026, with 9,374,999 shares issued at $3.20 and warrants for 18,749,998 shares at $2.95. Cash was $1.4M at quarter-end, but the private placement provides runway. The 10-Q includes full financial statements and MD&A, offering more detail than the earlier 8-K and press release.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 29.6% of the 1645 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FEMY was trading at $2.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $2.19 to $22.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Sep 29, 2026, 7:02 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $2.00 info
Change: -$0.380 (-16%) info
Market Cap: $16.75M info
FEMY
Sep 03, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $2.00 info
Change: -$1.04 (-34%) info
Market Cap: $16.75M info
FEMY
Aug 26, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $2.00 info
Change: -$0.8808 (-31%) info
Market Cap: $16.75M info
FEMY
Aug 19, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.00 info
Change: -$0.150 (-7%) info
Market Cap: $16.75M info
FEMY
Aug 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $2.00 info
Change: -$0.340 (-15%) info
Market Cap: $16.75M info